Carcinoid Tumor Panel Test
Comprehensive Neuroendocrine Tumor Detection and Monitoring
The Carcinoid Tumor Panel Test represents a sophisticated diagnostic approach for identifying and monitoring neuroendocrine tumors, specifically carcinoid tumors that originate from neuroendocrine cells throughout the body. These rare but significant tumors can develop in various organs, including the gastrointestinal tract, lungs, and other sites, often producing hormones and bioactive substances that lead to characteristic symptoms known as carcinoid syndrome.
What This Advanced Panel Measures
Our comprehensive Carcinoid Tumor Panel evaluates three critical biomarkers that provide essential information about neuroendocrine tumor activity:
- 5-Hydroxy Indole Acetic Acid (5-HIAA): Measured in 24-hour urine collection, this metabolite represents the primary breakdown product of serotonin and serves as a reliable marker for serotonin-producing carcinoid tumors.
- Chromogranin A: A protein secreted by neuroendocrine cells that functions as an excellent general marker for neuroendocrine tumors, regardless of their hormone production status.
- Serotonin (5-HT): Measured in serum, this neurotransmitter and hormone is frequently elevated in patients with carcinoid tumors, particularly those affecting the gastrointestinal system.
Who Should Consider This Essential Screening?
This comprehensive panel is particularly recommended for individuals experiencing symptoms suggestive of carcinoid syndrome or those with risk factors for neuroendocrine tumors:
- Patients presenting with unexplained flushing episodes, particularly facial flushing
- Individuals experiencing chronic diarrhea without clear gastrointestinal causes
- Those with wheezing or asthma-like symptoms not responsive to standard treatments
- Patients reporting heart palpitations or valvular heart disease of unknown origin
- Individuals with abdominal pain, cramping, or intestinal obstruction
- Patients with known neuroendocrine tumors requiring monitoring
- Those with family history of neuroendocrine disorders or multiple endocrine neoplasia
Significant Benefits of Early Detection
Undergoing the Carcinoid Tumor Panel Test offers numerous advantages for patient care and management:
- Early Diagnosis: Facilitates timely detection of neuroendocrine tumors before they progress to advanced stages
- Comprehensive Assessment: Provides multiple biomarker measurements for enhanced diagnostic accuracy
- Treatment Monitoring: Enables healthcare providers to track treatment effectiveness and disease progression
- Symptom Correlation: Helps establish connections between biochemical markers and clinical symptoms
- Risk Stratification: Assists in determining appropriate management strategies based on biomarker levels
Understanding Your Test Results
Interpreting your Carcinoid Tumor Panel results requires professional medical expertise, but general guidance includes:
- Elevated 5-HIAA: Typically indicates serotonin-producing carcinoid tumors, with levels often correlating with tumor burden
- Increased Chromogranin A: Suggests presence of neuroendocrine tumors and can be useful for monitoring treatment response
- Raised Serotonin Levels: Supports diagnosis of serotonin-secreting tumors and may correlate with symptom severity
- Normal Results: Generally indicate low likelihood of active carcinoid tumor, though clinical correlation remains essential
Your healthcare provider will interpret these results in the context of your symptoms, medical history, and other diagnostic findings to develop an appropriate management plan.
Test Pricing and Availability
| Test Component | Price Type | Amount (USD) |
|---|---|---|
| Carcinoid Tumor Panel Test | Discount Price | $326 |
| Carcinoid Tumor Panel Test | Regular Price | $450 |
Nationwide Accessibility
GGC DNA Diagnostics maintains testing facilities across the United States, ensuring convenient access to our Carcinoid Tumor Panel Test in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and numerous other locations. Our network of collection centers and partnerships with healthcare providers guarantees that comprehensive neuroendocrine testing is readily available nationwide.
Take Control of Your Health Today
Don’t let unexplained symptoms compromise your quality of life. The Carcinoid Tumor Panel Test provides crucial insights that can lead to accurate diagnosis and effective management of neuroendocrine disorders. Our specialized testing, combined with expert analysis and rapid turnaround times, ensures you receive the highest quality diagnostic care.
Schedule your Carcinoid Tumor Panel Test today by calling our dedicated healthcare line at +1(267) 388-9828 or book your appointment through our online portal. Early detection through comprehensive biomarker analysis can make a significant difference in managing neuroendocrine health effectively.
